These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26804061)

  • 1. Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation.
    Yang YY; He HQ; Cui JH; Nie YJ; Wu YX; Wang R; Wang G; Zheng JN; Ye RD; Wu Q; Li SS; Qian F
    Chem Biol Drug Des; 2016 Jun; 87(6):895-904. PubMed ID: 26804061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.
    Jing H; Sun W; Fan J; Zhang Y; Yang J; Jia J; Li J; Guo J; Luo S; Zheng Y
    Mol Med Rep; 2016 Apr; 13(4):3009-16. PubMed ID: 26935874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion.
    Zhou X; Huang J; Liu S; Cui J; Chen J
    Discov Med; 2024 Jun; 36(185):1231-1240. PubMed ID: 38926109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
    Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
    Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMAKO-20 as a New Multitarget Anticancer Prodrug Activated by the Tumor Specific CYP1B1 Enzyme.
    Cui J; Zhang X; Huang G; Zhang Q; Dong J; Sun G; Meng Q; Li S
    Mol Pharm; 2019 Jan; 16(1):409-421. PubMed ID: 30481041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1.
    Cui J; Zhou X; Huang J; Cui J; Chen J
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Zhao G; Han X; Cheng W; Ni J; Zhang Y; Lin J; Song Z
    Oncol Rep; 2017 Apr; 37(4):2277-2285. PubMed ID: 28260058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.
    Durchschein C; Hufner A; Rinner B; Stallinger A; Deutsch A; Lohberger B; Bauer R; Kretschmer N
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30380765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
    Gong K; Li W
    Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
    Yang Q; Ji M; Guan H; Shi B; Hou P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
    Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of DMAKO-05, a novel shikonin derivative, and its metabolism in rat liver microsome.
    Zhang X; Wang RB; Zhou W; Xiao S; Meng QQ; Li SS
    AAPS PharmSciTech; 2015 Apr; 16(2):259-66. PubMed ID: 25273027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect and mechanism of shikonin derivative SYUNZ-7].
    Huang H; Xie BF; Zhu XF; Feng GK; Zhou JM; Wang Y; Wu HQ; Huang ZS; Gu LQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1453-8. PubMed ID: 16351791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl participates in shikonin-induced apoptosis by negatively regulating phosphoinositide 3-kinase/protein kinase B signaling.
    Qu D; Xu XM; Zhang M; Jiang TS; Zhang Y; Li SQ
    Mol Med Rep; 2015 Jul; 12(1):1305-13. PubMed ID: 25815461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
    Lin HY; Chen W; Shi J; Kong WY; Qi JL; Wang XM; Yang YH
    Chem Biol Drug Des; 2013 Feb; 81(2):275-83. PubMed ID: 23066914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis.
    Lee JH; Han SH; Kim YM; Kim SH; Yoo ES; Woo JS; Jung GH; Jung SH; Kim BS; Jung JY
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33403388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.